Loading data for ADIL — first visit, this takes a few seconds.
Adial Pharmaceuticals, Inc. (ADIL)
NasdaqCM: ADIL
· 实时价格 · USD
4.90
-1.10 (-18.33%)
收盘价： Sep 11, 2026, 8:00 PM
4.89
-0.20%
盘后: 7:51 PM
股价、关键数字和最新消息，都在这一页。
Adial Pharmaceuticals, Inc.（ADIL）股价、分析与数据
暂无数据
| 买价 | 4.57 |
| 市值 | 14.4M |
| 营收（TTM） | n/a |
| 净利润（TTM） | -57.8M |
| 1.39 | |
| -14.34 | |
| n/a | |
| -0.66 | |
| 市净率（TTM） | -0.34 |
| 市销率（TTM） | 0.00 |
| 财报日期 | n/a |
| 卖价 | 3.08 |
| 成交量 | 108,441 |
| 20日均量 | 76,827 |
| 开盘价 | 6.06 |
| 前收盘价 | 6.00 |
| 日内区间 | 4.80 - 6.11 |
| 52周区间 | 1.31 - 10.75 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 ADIL
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The...
公司完整简介财报意外
Adial Pharmaceuticals 已于 Aug 14, 2026 发布季度财报：
- 营收为 $0 低于预期 $0, ， NaN% 同比增长.
- 每股收益为 -1.29 低于预期 -0.38, ， 71.33% 同比增长.
